APIC (Active Pharmaceutical Ingredients Committee): Guidance On Aspects Of Cleaning Validation In Active Pharmaceutical Ingredient Plants European Medicines Agency (EMA) : Guideline on setting health based exposure limits; Questions and answers on Guideline on setting health-based exposure limits USFDA Guide To Inspections : Validation Of Cleaning Processes PIC/S : Guideline On Setting Health Based Exposure Limits For Use In Risk Identification In The Manufacture Of Different Medicinal Products In Shared Facilities (PI 046-1 Annex 1 July 2018) TGA : Cleaning Validation – A regulatory perspective (Presentation) WHO TRS 1033 – Annex 2 : Points to consider when including Health-Based Exposure Limits (HBELs) in cleaning validation

USFDA Data Integrity and Compliance with Drug CGMP Questions and Answers – USFDA Guidance for Industry EMA (European Medicines Agency) Data Integrity Aug 2016 (European Medicines Agency) MHRA (Medicines & Healthcare products Regulatory Agency) ‘GXP’ Data Integrity Guidance and Definitions WHO TRS 1033 – Annex 4 : WHO Guideline on Data Integrity PIC/S Guidance on Data Integrity ; Good Practices For Data Management And Integrity In Regulated Gmp/Gdp Environments Comparison of EMA and FDA Guidance on Data Management and Data Integrity; Barbara W. Unger; Redica Systems Data Integrity checklist by Agilent (Useful checklist).

Excipient Risk Assessment (Europe) : Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use ( EC 2015/C 95/02) PIC/S Document: Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human Use

APIC (Active Pharmaceutical Ingredients Committee): Guidance On Aspects Of Cleaning Validation In Active Pharmaceutical Ingredient Plants European Medicines Agency (EMA) : Guideline on setting health based exposure limits; Questions and answers on Guideline on setting health-based exposure limits USFDA Guide To Inspections : Validation Of Cleaning Processes PIC/S : Guideline On Setting Health Based Exposure Limits For Use In Risk Identification In The Manufacture Of Different Medicinal Products In Shared Facilities (PI 046-1 Annex 1 July 2018) TGA : Cleaning Validation – A regulatory perspective (Presentation) WHO TRS 1033 – Annex 2 : Points to consider when including Health-Based Exposure Limits (HBELs) in cleaning validation

USFDA Data Integrity and Compliance with Drug CGMP Questions and Answers – USFDA Guidance for Industry EMA (European Medicines Agency) Data Integrity Aug 2016 (European Medicines Agency) MHRA (Medicines & Healthcare products Regulatory Agency) ‘GXP’ Data Integrity Guidance and Definitions WHO TRS 1033 – Annex 4 : WHO Guideline on Data Integrity PIC/S Guidance on Data Integrity ; Good Practices For Data Management And Integrity In Regulated Gmp/Gdp Environments Comparison of EMA and FDA Guidance on Data Management and Data Integrity; Barbara W. Unger; Redica Systems Data Integrity checklist by Agilent (Useful checklist).

Excipient Risk Assessment (Europe) : Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use ( EC 2015/C 95/02) PIC/S Document: Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human Use

Qvents – Discussion forum for Pharma Quality events, Regulatory Actions

Q: Controlled Correspondence / Scientific Advice with regulatory agencies

USFDA Controlled Correspondence Related to Generic Drug Development USFDA Guidance Document – Controlled Correspondence Related to Generic Drug Development – Draft Guidance. Cover Letter Attachments for Controlled Correspondences and ANDA Submissions – Guidance WHO Prequalification – Technical Advice ; Advice to Manufacturers EMA – Scientific advice and protocol assistance

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Discussion forum for Pharma Quality events, Regulatory actions (Warning letters, Recalls, 483s, Import alerts; Deviations, OOS, Complaints) and other Pharma Tech Ops topics

Qvents Knowledge sharing & learning platform

Qvents is a knowledge sharing platform focussed on Pharma Quality Systems, GMP and Regulatory topics. Qvents discusses different quality and regulatory events, what causes such events, what companies can do to prevent such events. You can post your comments and replies, seek clarifications and start new discussions. View what industry is doing, learn from industry professionals, peers and seniors, use the learnings for training, development, adopt for enhancing the systems and processes.

Qvents …Come alive with your expertise and knowledge

Qvents focusses on Pharma Quality Events (Qvents), Regulatory observations and actions. You can participate in discussions, contribute your ideas and perspectives, Qvents is a powerful medium where your expertise and knowledge on the subject can come alive, get peer reviewed & commented and get noticed…

Warning letters

USFDA Warning letters are discussed, with analysis of key deficiencies and observations, what can lead to the observations, what you should have in place to meet agency expectations and prevent such observations and evets at your site, company. Read, give your comments, seek clarifications and use the discussions for trainings and audit readiness at your facility.

USFDA 483s

Published USFDA 483s (Inspectional observations issued at the close of inspections) are reviewed and discussed focussing on what can lead to such observations, what you should have in place to meet agency expectations and prevent such observations at your manufacturing site. You can identify the inspector focus, review the post and comments, reply and seek clarifications and use the discussions for trainings and audit readiness at your facility.

Product Recall

Product recalls are cumbersome to execute and close, invite regulatory attention, leads to loss of reputation and harm the patient population if not executed adequately. The product recall posts discusses recalls due to GMP issues focussing on what can lead to such events, and what companies should have in place to prevent such events at the facilities

Discussion forum

Discussion forums on Pharma Tech Ops, Quality, regulatory topics..Post your queries and comments on various topics, learn from industry peers..For the pharma professionals to learn and grow together for better quality and better compliance

Check out the Guidelines page for comprehensive list of guidelines and updates, Learning Resources page for upcoming and archived Trainings and Webinars, News page for latest news on Pharma Quality and regulatory news.

User Profiles Page

Update your profile, get noticed. All your posts, comments, replies can also be viewed from your profile page and you control what others can view and cannot view. Search for profiles of Qvents users, view the profiles, proficiencies and expertise and connect. A great way for Pharma industry to professionals to get noticed and connected!!!

Follow us on

Search your Topics

Popular: Warning Letters, Recalls

Latest News

Baxter Warning Letter Highlights Beta-Lactam Contamination Risks and Sterile Manufacturing Control Gaps
October 30, 2026
Medical Device Labels in India To Display Sterilisation Facility License Number
August 31, 2026
Strides FDA 483 Flags Lapses in Microbiological Testing, Control of Computerised Equipment
June 8, 2026

Shared Beta-Lactam Facilities: Achieving Complete and Comprehensive Separation to Prevent Cross-Contamination

Recent USFDA warning letter, issued to Baxter (October 2026), citing inadequate beta lactam contamination controls once again highlight regulatory expectations

November 2, 2026 No Comments

FDA Warning Letter to Eurofins Flags Microbial Analytical Practices

USFDA has issued a Warning Letter to Eurofins SF Analytical Laboratories, Inc, Contract Testing Laboratory at Horsham, Pennsylvania in US

October 14, 2026 No Comments

CDSCO Guideline for Action on Spurious & NSQ Drugs

Amidst the heightened surveillance and enforcement actions initiated by different state licensing authorities (state FDAs) in India on Drugs and

September 1, 2026 No Comments

FDA issues Guidance on Container Closure Systems (CCS) for Human Drugs

The USFDA has released a new draft guidance, Container Closure Systems for Human Drugs and Biological Products, outlining principles for

August 24, 2026 No Comments

Dabur Facility Placed Under Import Alert

The USFDA has placed Dabur’s Dadra and Nager Haveli facility under Import Alert 66-40 in June 2026. This action follows

June 15, 2026 No Comments

Qvents Apps and Tools For QMS and GMP Processes

Qvents provides useful tools for QMS processes – Risk Assessments, Continuous Process Validations, Supply Chain Traceability Mapping of Drug Products. The Apps

May 23, 2026 No Comments

No more posts to show

Digital platform for Pharma TechOps professionals: Pharma GMP News, Quality & Regulatory Events, Warning letters & USFDA 483s, Product Recalls, Guidelines, Discussion Forums, Trainings, Pharma Jobs, Networking

Discussion forum for Pharma Quality events, Regulatory actions (Warning letters, Recalls, 483s, Import alerts; Deviations, OOS, Complaints) and other Pharma Tech Ops topics

Qvents Knowledge sharing & learning platform

Qvents …Come alive with your expertise and knowledge

Warning letters

USFDA 483s

Product Recall

Discussion forum

User Profiles Page

Qvents: Pharma Information, learning and knowledge platform

Qvents publish news and expert review posts on Pharma Quality & Regulatory events, Warning letters, 483s, alerts, recalls, enforcement actions; Deep review of What causes the events, What should be in place to prevent such events, Actions & CAPAs.

Be informed about current concerns and focus areas of regulators and auditors; Share your views, comments, hear from industry peers….

Qvents Forums

Discussion forums on Pharma GMP, Quality, Regulatory, TechOps topics – Create your Topics, Post your Queries, Join discussions on current Topics in the Forum, post your comments!!!

Pharma Guidelines

Access the most UpToDate Pharma Quality, Regulatory, Technical Guidelines / Guidances from different agencies; All related guidelines on each topic from different agencies at one place (USFDA, EDQM, EMA, WHO, TGA, ICH, Professional bodies like ISPE, PDA and others)

Qvents Learning Resources

Qvents list select Learning Resources - Trainings, Webinars, Seminars, Conferences from different agencies, professional bodies, organisations, SMEs and Experts. Register for upcoming events; View past events from archives.

Pharma Jobs

Browse Pharma job openings. Search jobs with key words. Register your profile in Qvents and Search for Jobs matching your profile.

Pharma Job Listing / Employers

List your Job Openings with Qvents; Search for profiles matching the jobs requirements; View profiles, Connect with candidates.

Pharma Job Listing

Create Company account, Company Admin and Company Users. Post Job Opportunities.

There are no charges!!! Posting Jobs at Qvents.in is free.

A Qvents representative will verify and confirm your Company account. After verification you can post Job opportunities with the Company on the Qvents portal.

Subscribe to Qvents.

Get email updates on new Posts, News, new Forum Discussions & Topics.

Update your profile at Qvents. Search for Jobs matching your profiles.
Updating your profile helps in networking with Industry peers. Helps Employers to find your profile and connect with you

Qvents Tags

Use Tags to Zip through Qvents Posts and News

From the Tags page pick the Tags and Click Submit to get content matching selected Tags:

FDA Auditors, Audit Citing’s, Regulatory Events, Recalls & Reasons, Regulatory Agencies…

Qvents Apps & Tools

Nitrosamines Risk Assessment for APIs, Excipients, Drug Products, Continuous Process Validation (CPV) & Control Charts, Supply Chain Mapping….

Open the Apps, Fill in the forms, Get the results with maps, charts, recommendations…
The apps & tools are designed to comply with the regulatory guidance. Contact Qvents for any support.

Quality Insights, Templates

Often regulatory requirements and guidances are very generic, broad based with minimum practical implementation guidelines.

Qvents Quality Insights present practical approaches for implementation of the regulatory guidances with user-friendly documentation templates

Qvents Posts

View All

Shared Beta-Lactam Facilities: Achieving Complete and Comprehensive Separation to Prevent Cross-Contamination

November 2, 2026 No Comments

FDA Warning Letter to Eurofins Flags Microbial Analytical Practices

October 14, 2026 No Comments

CDSCO Guideline for Action on Spurious & NSQ Drugs

September 1, 2026 No Comments

Qvents Forums

View All

Is an ELEMENTAL IMPURITIES RISK ASSESSMENT required for finished containerized WATER FOR INJECTION?

baole212

2 days, 14 hours ago

ANDAs, Formulation Dossiers

9 Views

0 Likes

0 Replies

What Should Pharma Buyers Check Before Selecting an API Supplier?

royjohnston92@gmail.com

1 week, 4 days ago

APIs & Intermediates

42 Views

0 Likes

0 Replies

Excipient Risk Assessment-EUGMP

QueriesQvents

11 months ago

Excipients

274 Views

0 Likes

0 Replies

Supply Chain Traceability Mapping – EUGMP

Venkitesh TK

11 months ago

Materials, Supply chain

254 Views

0 Likes

0 Replies

Method Transfer USFDA 483

Qvents Team

1 year, 1 month ago

Methods, Validations

346 Views

0 Likes

0 Replies

Follow Us..............Share

Popular: Warning Letters, Recalls

Qvents News

View All

Baxter Warning Letter Highlights Beta-Lactam Contamination Risks and Sterile Manufacturing Control Gaps
October 30, 2026
Medical Device Labels in India To Display Sterilisation Facility License Number
August 31, 2026

Guidelines

View All

Accordian

API DMF (Drug Master File)

Clean Rooms & HVAC Systems

Cleaning Validation

Computer systems validation (CSV), Electronic Data Controls

Controlled Correspondence / Scientific Advice with regulatory agencies

Data Integrity

Excipients related

Excipient Risk Assessment (Europe): Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use ( EC 2015/C 95/02)
PIC/S Document: Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human Use

Pharma Jobs

View All

Senior Manager QA
Lupin Limited
Senior Manager – API Production
Sun Pharmaceutical Industries Ltd
Sr Executive – Production QMS
Sun Pharmaceutical Industries Ltd
Senior Executive – Production
Sun Pharmaceutical Industries Ltd

Qvents: Pharma Information, learning and knowledge platform

Be informed about current concerns and focus areas of regulators and auditors; Share your views, comments, hear from industry peers….

Qvents Forums

Discussion forums on Pharma GMP, Quality, Regulatory, TechOps topics – Create your Topics, Post your Queries, Join discussions on current Topics in the Forum, post your comments!!!

Pharma Guidelines

Qvents Learning Resources

Pharma Jobs

Browse Pharma job openings. Search jobs with key words. Register your profile in Qvents and Search for Jobs matching your profile.

Pharma Job Listing / Employers

List your Job Openings with Qvents; Search for profiles matching the jobs requirements; View profiles, Connect with candidates.

Subscribe to Qvents.

Get email updates on new Posts, News, new Forum Discussions & Topics.

Update your profile at Qvents. Search for Jobs matching your profiles.
Updating your profile helps in networking with Industry peers. Helps Employers to find your profile and connect with you